1. Home
  2. Live Updates
  3. Lostridium difficile

Live Breaking News & Updates on Lostridium difficile

Stay informed with the latest breaking news from Lostridium difficile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lostridium difficile and stay connected to the pulse of your community

Rethinking the germ theory: A balanced take on microbes and disease outcomes

Review explores the complexities of infectious disease outcomes through a balanced perspective, emphasizing the interplay between pathogenic microbes and host conditions, challenging the traditional germ-disease theory by proposing a more integrated view that considers both pathogen virulence and host immunity's impact on disease manifestation.

Aids , Ntigen , Ell , Lostridium , Lostridium-difficile , Iagnostic , Enetic , Nfectious-diseases , Nterferon , Icroorganism , Psonization

It's Time to Evolve Beyond FMTs and Advance LBPs

The FMT era has been productive, but now it’s time to rally together as an industry to accelerate next-generation LBP drug discovery, development and FDA approval.

Weight-loss , Besity , Verweight , Diabetes , Massachusetts , Medical-devices , Obesity , Startups , Healthcare-innovation , Edcity-news , Medcity-news

Researchers identify genes that may improve success of fecal microbe transplants

Fecal microbe transplants from healthy donors can treat patients with recurrent Clostridium difficile infections. However, after tens of thousands transplants, little was known about which donor strains provide long-term engraftment, and which engraft early after the transplant.

New-york , United-states , Danielle-ellis , Hyunmin-koo , Icahn-school-of-medicine-at-mount-sinai , Marnixe-heersink-school-of-medicine , Department-of-genetics , Department-of-cell , University-of-alabama-at-birmingham , Icahn-school , Mount-sinai , Scientific-reports

What is the relationship between intestinal stem cells and the gut microbiota in regenerative medicine?

Researchers explored the relationship between intestinal stem cells (ISCs) and the gut microbiota and its role in maintaining intestinal health.

Helse-fonna , Image-credit , Stem-cells , Acteria , Ell , Lostridium , Lostridium-difficile , Igestion , Ysbiosis , Astrointestinal-tract , G-protein

First Capsule Form of Stool-Based Gut Infection Treatment Gets FDA Clearance

FDA approved the first drug made from helpful bacteria found in human waste to treat severe gut illnesses.

United-states , American , Majdi-osman , Edward-jenner-pexels , Ferring-pharmaceuticals , Drug-administration , Edward-jenner , Massachusetts-based-seres-therapeutics , Scientists-identify-protein-linked , Pancreatic-cancer-growth , Drug , Edicine

Seres's Bacteria in a Pill Becomes First FDA-Approved Oral Microbiome Therapy

Recurrent Clostridioides difficile infection can be treated with fecal microbiota transplants. FDA approval of Seres Therapeutics’ Vowst makes it the first oral microbiome therapy.

Vendanta-biosciences , Seres-vowst , Eric-shaff , Centers-for-disease , Seres-therapeutics , Disease-control , Ferring-pharmaceutical , Flagship-pioneering , New-england-journal , Weight-loss , Besity , Verweight

The burden of Clostridioides difficile infections in the United States

Researchers review existing data on Clostridioides difficile infections among United States residents.

United-states , Us-centers-for-disease , Image-credit , Disease-control , C-diff , Lostridium-difficile , Ntibiotic , Nxiety , Ovid-19 , Epression , Iarrhea

UAB researchers report lack of predictability for fecal microbial transplants without prior antibiotic therapy

A fecal microbial transplant -; giving a recipient fecal matter from a donor to change the recipient's gut microbial community in the colon -; has been a successful last resort therapy for people with recurrent Clostridium difficile infection after multiple rounds of suppressive antibiotics have eliminated the recipient microbial community.

Hyunmin-koo , Emily-henderson , Department-of-genetics , Marnixe-heersink-school-of-medicine , University-of-alabama-at-birmingham , Department-of-cell , Casey-morrow , Genomics-industry-focus , Integrative-biology , Antibiotic , Ancer , Lostridium

PLF announces See C. Diff campaign

The Peggy Lillis Foundation announced its annual gala to kick off its fourth See C. Diff campaign as part of C. Diff Awareness Month.

Drug-administration , Peggy-lillis-foundation , Dentistry , Ental-industry , Entist , Ental-professional , Ental-practice-management , Ental-hygienist , C-diff , Lostridium-difficile , C-diff-awareness-month